JIPMER grants Study leave for BSc Allied Health Sciences II and Ill-Year courses

Published On 2021-03-14 07:30 GMT   |   Update On 2022-12-15 11:59 GMT

Puducherry: Through a recent notice, JIPMER Academic Section has intimated the grant of Study leave for B.Sc.(Allied Health Sciences) II & Ill-Year courses students for the March/April 2021-semester examinations. It is to be noted that the examination schedule for the III & IV semester students of B.Sc (Allied Health Sciences) at JIPMER was revised to start from 23-03-21 and...

Login or Register to read the full article

Puducherry:  Through a recent notice, JIPMER  Academic Section has intimated the grant of Study leave for B.Sc.(Allied Health Sciences) II & Ill-Year courses students for the March/April 2021-semester examinations. It is to be noted that the examination schedule for the III & IV semester students of B.Sc (Allied Health Sciences) at JIPMER was revised to start from 23-03-21 and 22-03-21 respectively. 

Now the institute has decided to grant study leave to the students according to the revised schedule of examination. According to the notice, the B.Sc.(AHS) courses II year (III-Semester) students are granted study leave for the period from 16.03.2021 to 22.03.2021. Similarly, students of  Ill-Year B.Sc.(AHS) course (V–semester) will get the study leave from 15.03.2021 to 21.03.2021.

Through the same notice, the institute has also intimated that there will be no vacation after completion of the examinations.


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News